Orangeburg, NY, Dec. 19, 2013 (GLOBE NEWSWIRE) -- Orangeburg, NY - December 19, 2013- Vision-Sciences, Inc. (NASDAQ: VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, has entered into an agreement with 21st Century Oncology, Inc., under which Vision-Sciences is 21st Century's Preferred Vendor of Choice for endoscopy equipment used for evaluation and treatment procedures in multiple therapeutic and cancer care areas. The equipment agreement includes several of the company's advanced fiberoptic and video based endoscopic imaging products, including flexible laryngoscopes, transnasal esophagoscopes, bronchoscopes, and cystoscopes, all of which are utilized in the diagnosing, treatment, and management of head and neck, esophageal, lung, and bladder cancers.
"We are pleased to have forged this multi-disciplinary agreement with 21st Century Oncology, Inc. This is another important validation of our 'always ready, always sterile' EndoSheath technology platform, which provides high-quality endoscopy while protecting patients against the hazards of inadequate endoscopic reprocessing," said Howard Zauberman, President and Chief Executive Officer of Vision-Sciences. "We look forward to the continued growth of our franchise enabled by this agreement, which affords us the opportunity to outfit each of 21st Century's 166 treatment centers in the U.S. and Latin America with state of the art imaging technology and the only sterile endoscopic solution in the market.
"In keeping with our commitment to delivering high quality care for patients, we have selected Vision-Sciences as our Preferred Vendor of Choice for endoscopy equipment," said Kathy Tolentino, Director Purchasing, 21st Century Oncology, Inc. "Vision-Sciences' EndoSheath technology offers the only sterile, disposable option in flexible endoscopic treatment for the enhanced safety of patients. This agreement provides us the most efficient and cost-effective manner to perform safe, efficacious endoscopic management."
About Vision-Sciences, Inc.
Vision-Sciences, Inc. designs, develops, manufactures and markets products for flexible endoscopy. The Company's unique product lines feature a streamlined visualization system and proprietary sterile disposable microbial barrier, known as EndoSheath® technology, providing users with efficient and cost effective endoscope turnover while enhancing patient safety. Information about Vision-Sciences' products is available at www.visionsciences.com.
Vision-Sciences owns the trademarks Vision Sciences™ and Slide-On™ and the registered trademarks EndoSheath®, EndoWipe® and The Vision System®.
About 21st Century
21st Century Oncology, Inc., which operates and manages radiation treatment centers primarily under the name 21st Century Oncology, offers a comprehensive range of radiation treatment alternatives and focuses on delivering academic-quality, cost-effective patient care in a personal and convenient setting. The Company operates 166 treatment centers, including 133 centers located in 16 U.S. states and 33 centers in six Latin American countries. The Company holds market-leading positions in most of its domestic local markets and abroad. 21st Century Oncology is headquartered in Fort Myers, Florida.
Keith Darragh Lisa Wilson
VP, Finance President
Vision-Sciences, Inc. In-Site Communications, Inc.
(845) 365-0600 (212) 452-2793